Trial Profile
A Clinical Study to Determine the Pharmacokinetics of Oraxol in Breast Cancer Patients
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 31 Jul 2021
Price :
$35
*
At a glance
- Drugs Encequidar+paclitaxel (Primary)
- Indications Advanced breast cancer
- Focus Pharmacokinetics
- Sponsors Athenex
- 17 Jun 2020 Status changed from recruiting to completed.
- 04 Jun 2019 Results (n=28) presented at the 55th Annual Meeting of the American Society of Clinical Oncology
- 22 Oct 2018 Results presented in an Athenex media release.